{"id":"W2578812188","doi":"10.1016/j.jaip.2016.11.026","title":"Real-Life Outcomes for Patients with Asthma Prescribed Spacers for Use with Either Extrafine- or Fine-Particle Inhaled Corticosteroids","year":2017,"lang":"en","type":"article","venue":"The Journal of Allergy and Clinical Immunology In Practice","topic":"Inhalation and Respiratory Drug Delivery","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"ca_institutions":"McMaster University","funders":"Efficacy and Mechanism Evaluation Programme; Medical Research Council; Genentech; National Institutes of Health; AstraZeneca; Chiesi Farmaceutici; Respiratory Effectiveness Group; Sunovion; Regeneron Pharmaceuticals; Teva Pharmaceutical Industries; National Heart, Lung, and Blood Institute; Pfizer; British Lung Foundation; Sanofi; Amgen; GlaxoSmithKline","keywords":"Medicine; Fluticasone propionate; Cohort; Asthma; Exacerbation; Rate ratio; Pediatrics; Inhalation; Fluticasone; Internal medicine; Cohort study; Anesthesia; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001072214,0.000136887,0.0004360565,0.00004213991,0.0002243017,0.00004523138,0.0001592153,0.0001462784,0.00002340142],"category_scores_gemma":[0.005403565,0.00006338926,0.00007954672,0.00003555091,0.0004097115,0.0005706138,0.00004003596,0.0004132879,0.000001826248],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002046231,"about_ca_system_score_gemma":0.0002112603,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002878816,"about_ca_topic_score_gemma":0.0002375482,"domain_scores_codex":[0.9985595,0.0002661318,0.0006782112,0.0001334804,0.0001596853,0.0002030058],"domain_scores_gemma":[0.9944684,0.003317751,0.001137948,0.0003533048,0.0006235223,0.00009910729],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.4387234,0.004316889,0.5282775,0.000038241,0.0142799,0.0002689747,0.001274476,0.00008866176,0.0003417621,0.0004721177,0.001044476,0.01087361],"study_design_scores_gemma":[0.03198477,0.01273727,0.9461166,0.0001537889,0.001185399,0.0002309144,0.0009553612,0.0003316763,0.00008555216,0.00001047205,0.006056336,0.0001518172],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9910322,0.00009825322,0.0003571224,0.007668527,0.0002256391,0.0005309986,0.000003518166,0.000006190196,0.00007754486],"genre_scores_gemma":[0.9940686,0.0009880258,0.002397903,0.001517112,0.00008744632,0.00001322977,0.000002079138,0.00002428862,0.0009013781],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4178391,"threshold_uncertainty_score":0.6468962,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05393418058679038,"score_gpt":0.368722170770401,"score_spread":0.3147879901836106,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}